Skip to Content

Harvard Bioscience Inc HBIO

Morningstar Rating
$3.16 −0.02 (0.63%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HBIO is trading at a 299% premium.
Price
$3.14
Fair Value
$7.40
Uncertainty
Very High
1-Star Price
$15.82
5-Star Price
$4.13
Economic Moat
Sqvsj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HBIO is a good fit for your portfolio.

Trading Information

Previous Close Price
$3.18
Day Range
$3.093.20
52-Week Range
$3.096.20
Bid/Ask
$2.00 / $3.16
Market Cap
$137.24 Mil
Volume/Avg
336,626 / 96,676

Key Statistics

Price/Earnings (Normalized)
28.52
Price/Sales
1.26
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
416

Comparables

Valuation

Metric
HBIO
TECH
688315
Price/Earnings (Normalized)
28.5245.1039.75
Price/Book Value
1.996.492.24
Price/Sales
1.2611.582.63
Price/Cash Flow
22.4542.1021.28
Price/Earnings
HBIO
TECH
688315

Financial Strength

Metric
HBIO
TECH
688315
Quick Ratio
0.762.491.86
Current Ratio
1.884.082.40
Interest Coverage
−1.4514.52109.58
Quick Ratio
HBIO
TECH
688315

Profitability

Metric
HBIO
TECH
688315
Return on Assets (Normalized)
3.33%10.95%5.06%
Return on Equity (Normalized)
6.35%14.98%7.69%
Return on Invested Capital (Normalized)
6.15%12.39%7.55%
Return on Assets
HBIO
TECH
688315
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncKtvfngtjwCpng$142.2 Bil
BDX
Becton Dickinson & CoQscvksvbFxyxzcq$67.8 Bil
ALC
Alcon IncJyclmqfgdSypvhz$44.6 Bil
RMD
ResMed IncMyyljqywtKrzgk$31.3 Bil
CLPBY
Coloplast A/S ADRLnqmznxfyGhh$28.0 Bil
WST
West Pharmaceutical Services IncBlhlfcshlnVqzvb$24.5 Bil
COO
The Cooper Companies IncTxnjrsrbMsgqxy$18.8 Bil
BAX
Baxter International IncZjhdspfqsDnnbw$17.3 Bil
HOLX
Hologic IncYqkfylsTznkypr$17.2 Bil
TFX
Teleflex IncHwqLdz$10.3 Bil

Sponsor Center